One important thing happened in pharma product security this year, and one important thing did not. What did not happen was passage of a federal law on product serialization—it was intensively debated in Congressional committees (even as a spate of […]
Read MoreBack in December, I editorialized with the headline, “Fix the Drug Shortage Problem—Now,” to call attention to a problem that is no one company’s or organization’s fault, but which is a collective black eye on the entire healthcare delivery system. […]
Read MoreAmerican TV crews were in Winnipeg this spring continuing their investigation of sales of counterfeit versions of the cancer drug Avastin into the American market. With such attention focused on the failings of the North American drug wholesale market, there […]
Read MoreSerialization of pharmaceutical packages has been a hot topic in the last 10 years, as we seek to prevent counterfeiting and diversion of products in commercial supply chains. Proponents of the technology, both inside and outside the industry, highlight the […]
Read MoreOver the course of human history, we have seen two big advances in health outcomes. The first wave, beginning in the mid-19th century, came from the adoption of modern hygiene practices, which sharply reduced medical infections and improved post-surgery survival […]
Read MoreThe Federal Trade Commission has closed its investigation of Express Scripts, Inc.’s proposed acquisition of Medco Health Solutions. As a result of the evidence collected during an intensive eight-month investigation, we conclude that the proposed transaction is not likely to […]
Read MoreThe 2012–13 Occupational Outlook Handbook* has just been published by the Bureau of Labor Statistics of the US Dept. of Labor. That news might be important if you have a college-age child who is doing some long-term career planning, or […]
Read MoreWhile the drug wholesaling industry appears reasonably healthy right now, the ongoing generic drug price war among retail pharmacies will create the risk of reduced wholesaler profitability. Understanding this dynamic is crucial for predicting the future of wholesaler relationships with […]
Read MoreOn Feb. 9, FDA released a batch of some of the most important documents in recent memory: how it plans to regulate biosimilars. The three documents—which will have been examined an criticized in detail by the time you read […]
Read MoreFor pharmaceutical companies in 2012, supply chains will play a major role in their ability to adapt, consolidate or refocus their core business segments. The world will continue to throw new obstacles and challenges for moving products and materials into […]
Read More